We tested a hypothesis that the interactions of Tau phosphorylation, IL-6 elevation and mitochondrial dysfunction following sevoflurane treatment caused synaptic loss in young mice, leading to cognitive impairment in the mice. This evidence concerns the gene MAPT and Cognitive impairment.